What Causes Villous Atrophy and Can the Villi Recover?

Villous atrophy happens when the tiny, finger-like projections lining the small intestine become flattened or destroyed, cutting the surface area available for absorbing nutrients. Celiac disease is the most recognized cause, but it is far from the only one: certain medications, infections, autoimmune conditions, and chronic environmental exposures can all damage villi. Whether and how quickly they recover depends on identifying and removing the trigger, and on the regenerative capacity of intestinal stem cells that reside deep in the crypts between those villi.

How the Intestinal Lining Normally Renews Itself

The small intestine replaces its entire lining roughly every three to five days, making it one of the fastest-renewing tissues in the body. This turnover is driven by a specific population of stem cells marked by a receptor called Lgr5, which sit at the base of the intestinal crypts. Under normal conditions, these Lgr5-positive cells are the exclusive engine of epithelial self-renewal along the entire length of the small intestine, a process that depends on a signaling molecule called R-spondin.1PubMed Central. Lgr5+ Stem Cells Maintain Apex Position in Cell Hierarchy of the Intestinal Epithelium During Homeostasis and Injury New cells born in the crypt migrate upward along the villus, mature into absorptive cells, and are eventually shed from the tip. When this conveyor belt works properly, the villi stay tall and healthy. When something disrupts either the stem cells or the balance between new cell production and cell death, the villi flatten.

These stem cells are also remarkably resilient. After localized damage to a crypt, neighboring Lgr5-positive stem cells can migrate toward the damaged area and restore normal architecture within about 24 hours.2Scientific Reports. Intestinal crypts recover rapidly from focal damage with coordinated motion of stem cells that is impaired by aging That speed explains why the gut can bounce back from short insults like a stomach bug. The trouble starts when the damage is chronic, widespread, or driven by an immune system that won’t stand down.

Celiac Disease and the Immune Assault on Villi

Celiac disease is the classic and most thoroughly studied cause of villous atrophy. It is a T-cell-mediated immune disorder triggered by dietary gluten in genetically predisposed people.3PubMed. Intraepithelial lymphocytes in celiac disease immunopathology The process involves two arms of the immune system working in concert. In the tissue beneath the surface lining, gluten-specific CD4-positive T cells mount an inflammatory response. Meanwhile, in the epithelium itself, a separate population of immune cells called intraepithelial lymphocytes acquires the ability to directly kill the cells lining the gut.

What makes this particularly destructive is that the intraepithelial lymphocytes essentially become reprogrammed. In a healthy intestine, these cells carry mostly inhibitory receptors that keep them in check. In active celiac disease, a signaling molecule called interleukin-15 pushes them to express activating natural killer cell receptors instead. Once armed with those receptors, the lymphocytes can destroy epithelial cells independent of any specific gluten signal, essentially behaving like natural killer cells let loose on the gut lining.4Medical Research Archives. Pathology of celiac disease: An insight about etiopathogenesis, pathophysiology and histologic diagnosis This helps explain why even tiny amounts of gluten can sustain damage: once the immune licensing is in place, the destruction becomes somewhat self-perpetuating.

Interestingly, researchers have found that some people carry the antibodies associated with celiac disease but never develop villous atrophy, a state called potential celiac disease. In these individuals, the cytotoxic licensing of intraepithelial lymphocytes appears to be incomplete, with preserved regulatory pathways and reduced epithelial stress signaling preventing the final step of tissue destruction.5PubMed. From Autoimmunity to Intestinal Tissue Damage: Insights From Potential Celiac Disease as a Paradigm of Disease Progression Understanding what keeps those brakes engaged is an active area of research.

The Role of Cell Death in Flattening the Villi

Villous atrophy is sometimes described as if the villi are simply “worn down,” but the cellular reality is more specific. The flattening occurs when the rate of cell death in both the villi and the underlying crypts overwhelms the rate of new cell production. In celiac disease, crypt apoptosis (programmed cell death at the base, where stem cells live) is markedly elevated during active disease and correlates with the severity of flattening: total villous atrophy is associated with higher levels of crypt cell death than partial atrophy.6PubMed Central. An association between crypt apoptotic bodies and mucosal flattening in celiac disease patients exposed to dietary gluten This matters because it shows the damage reaches down into the regenerative compartment, not just the mature cells on the villus surface.

Inflammatory signaling molecules like TNF also contribute to villous loss. Research has shown that when a protective cellular recycling mechanism called autophagy is impaired in intestinal epithelial cells, those cells become acutely sensitive to TNF-triggered apoptosis, leading to villous atrophy. Blocking TNF signaling rescues the villi in these models.7PubMed Central. Atg14 protects the intestinal epithelium from TNF-triggered villus atrophy While that work comes from animal studies, it illustrates how the balance between inflammatory signaling and cellular defense determines whether villi survive or collapse.

Causes Beyond Celiac Disease

When a biopsy shows villous atrophy, celiac disease is the first suspect, but it is not the only defendant. A review of enteropathies in the Mayo Clinic Proceedings describes villous atrophy as typically producing severe malabsorptive symptoms that lead to nutritional deficiencies and electrolyte abnormalities, regardless of the underlying cause.8Mayo Clinic Proceedings. Not All That Flattens Villi Is Celiac Disease: A Review of Enteropathies The list of non-celiac causes is long, but a few deserve special attention because they are underrecognized.

Medication-Induced Enteropathy

A class of blood pressure drugs called angiotensin II receptor blockers (ARBs) can cause a condition that looks almost identical to celiac disease on biopsy, complete with villous atrophy and increased intraepithelial lymphocytes. Olmesartan is the most frequently implicated agent, but cases have been increasingly recognized with other ARBs including losartan.9PubMed Central. Losartan-Induced Sprue-Like Enteropathy Presenting With Isolated Ileal Villous Atrophy: A Report of a Rare and Atypical Case The mechanism is not fully understood, but researchers suspect it involves either disruption of the gut’s immune balance through effects on transforming growth factor, or a pro-apoptotic effect on intestinal cells when excess circulating angiotensin II binds to a secondary receptor.10PubMed Central. Olmesartan-Induced Enteropathy: An Unusual Cause of Villous Atrophy The long gap between starting the medication and developing symptoms, often months to years, makes this easy to miss. Recovery after stopping the drug is typically good, which makes it critical to consider medications as a cause before committing someone to a lifelong gluten-free diet.

Infections and Parasites

Acute infections can damage villi, though in most cases the effect is temporary and mild. Giardia, a common waterborne parasite, occasionally causes villous changes, but in a study of children with confirmed giardiasis who did not also have celiac disease, only about 3% had partial villous atrophy.11PubMed. Does Giardia lamblia cause villous atrophy in children?: A retrospective cohort study of the histological abnormalities in giardiasis Other infections that can flatten villi include tropical sprue (linked to bacterial overgrowth in tropical regions), HIV enteropathy, and certain viral infections. In most infectious cases, treating or clearing the pathogen allows the villi to regenerate.

Autoimmune Enteropathy

Autoimmune enteropathy is a rare condition in which the body produces antibodies against its own intestinal lining. The mechanism of cell death differs from celiac disease: rather than lymphocytes directly killing epithelial cells through contact, the immune system uses antibody-dependent cellular cytotoxicity, where antibodies tag the epithelial cells for destruction by other immune cells.12PubMed Central. Mechanisms of villous atrophy in autoimmune enteropathy and coeliac disease This distinction matters for treatment: autoimmune enteropathy does not respond to a gluten-free diet and usually requires immunosuppressive therapy.

Environmental Enteropathy

In regions with poor sanitation, chronic exposure to fecal pathogens can cause a subclinical condition characterized by villous atrophy, crypt hyperplasia, and inflammation of the intestinal tissue. This condition, called environmental enteric dysfunction, affects millions of people in low- and middle-income countries and contributes to malnutrition and stunted growth in children. A landmark study in the 1960s found that 40% of Peace Corps volunteers stationed in what is now Bangladesh developed signs of malabsorption, and none of their small intestinal biopsies showed normal villous architecture. Critically, the damage appeared to be reversible when volunteers returned to the United States, with no lasting consequences in most cases.13Oxford Academic (The Journal of Infectious Diseases). Environmental Enteric Dysfunction: Reemergence of an Old Disease This finding underscores a theme that runs through all causes of villous atrophy: remove the ongoing insult, and the gut generally has the machinery to rebuild.

How Quickly Do Villi Recover on a Gluten-Free Diet?

For celiac disease specifically, the evidence paints a picture that is more encouraging for children than for adults. In a long-term pediatric follow-up study, children who had only mild damage (Marsh type II) at diagnosis normalized within the first year on a gluten-free diet. Among children with more advanced villous atrophy (Marsh type III), about 81% achieved histologic remission within one year, rising to about 92% within two to three years and nearly 98% with longer follow-up.14Archives of Medical Science. Histologic recovery among children with celiac disease on a gluten-free diet. A long-term follow-up single-center experience

Adults tend to heal more slowly. In a study of adults with celiac disease, the confirmed rate of mucosal recovery at two years was only about 34%, climbing to roughly 66% at five years.15PubMed Central. Mucosal Recovery and Mortality in Adults with Celiac Disease after Treatment with a Gluten-Free Diet Age at diagnosis plays a role: one study observed that adults over 65 had a mucosal remission rate of about 79%, compared to 82% in adults aged 18 to 65, a relatively small difference.16PubMed Central. Outcomes in Adults with Celiac Disease Following a Gluten-Free Diet The slower adult recovery rate may reflect accumulated damage, less robust stem cell activity, or the practical difficulty of maintaining a truly strict gluten-free diet over years.

When Recovery Stalls

Persistent villous atrophy despite a gluten-free diet is a recognized and frustrating problem. In about 80% of such cases, the culprit is either incomplete dietary adherence or simply slow responsiveness: the villi are healing, just not fast enough for the follow-up biopsy to catch it. As little as 50 milligrams of gluten per day, an amount easily hidden in processed foods and medications, can sustain epithelial damage.17Gastroenterology. Nonresponsive Celiac Disease That threshold is remarkably low: 50 milligrams is roughly a few crumbs of ordinary bread.

In the remaining roughly 20% of cases with persistent villous atrophy, something more serious may be at play. This is the territory of refractory celiac disease, which is classified into two types. Type 1 refractory celiac disease features normal-looking intraepithelial lymphocytes and generally has a better prognosis, sometimes responding to immunosuppressive treatment. Type 2 is defined by the presence of abnormal, clonal intraepithelial lymphocytes.18PubMed Central. Classification and management of refractory coeliac disease Type 2 carries a significantly worse outlook. Compared to type 1, patients with type 2 refractory disease are more likely to present with malnutrition, ulcerative jejunitis (deep ulcers in the jejunum), and protein-losing enteropathy. Large ulcerations greater than one centimeter in diameter were observed only in the type 2 group.19Gastroenterology. Presentation and Long-Term Follow-up of Refractory Celiac Disease: Comparison of Type I With Type II Type 2 refractory celiac disease is also a precursor to a rare but serious intestinal lymphoma.

Why Blood Tests Can Miss Persistent Damage

Many people with celiac disease rely on blood tests for tissue transglutaminase (tTG) or endomysial antibodies (EMA) to monitor whether their gut is healing. These tests are good at ruling celiac disease in at the time of diagnosis, but they are surprisingly poor at detecting persistent villous atrophy once someone is on a gluten-free diet. A meta-analysis found that the tTG antibody test identified persistent villous atrophy with a sensitivity of only about 50%, meaning it missed half of the people who still had damage. The EMA test fared similarly, with a sensitivity of about 45%.20Gastroenterology. Tests for Serum Transglutaminase and Endomysial Antibodies Do Not Detect Most Patients With Celiac Disease and Persistent Villous Atrophy on Gluten-free Diets: a Meta-analysis In other words, normal antibody levels do not guarantee that the villi have healed. This is one reason gastroenterologists recommend follow-up biopsies rather than relying on blood work alone to confirm mucosal recovery.

Antibody levels at diagnosis and during follow-up do carry some prognostic information. Higher transglutaminase antibody titers, both initially and over time, have been associated with poorer histologic outcomes.21PubMed. Assessing mucosal recovery in celiac disease – Time to diagnosis and histological severity as determining factors But the relationship is not tight enough to substitute for directly looking at the tissue.

Biopsy Pitfalls That Complicate the Picture

Even biopsy, the gold standard for assessing villous atrophy, has real limitations. Villous damage in celiac disease and other enteropathies is not always uniform across the duodenum. Patchy villous atrophy, where some areas are flattened while adjacent areas look normal, is well documented. If the endoscopist happens to sample a healthier-looking patch, the biopsy may underestimate the severity of the disease.22Elsevier. Review Tricks of the trade: How to avoid histological Pitfalls in celiac disease This is why guidelines typically recommend taking multiple biopsies from different sites in the duodenum.

Beyond sampling location, how the biopsy is handled in the lab matters enormously. If the tissue specimen is poorly oriented when it is cut for microscopic examination, villi can appear artificially shortened, making normal tissue look atrophied. The villus-to-crypt ratio and the count of intraepithelial lymphocytes both depend on proper orientation. A pathologist looking at a badly cut section may see something that mimics disease when no disease exists, or miss mild atrophy because the landmarks are distorted. This technical reality means that a single ambiguous biopsy result, especially one that does not match a patient’s clinical picture, deserves careful re-evaluation before it drives treatment decisions.

Elemental Diets and Mucosal Healing Beyond Gluten Removal

When villous atrophy stems from something other than celiac disease, or when a patient cannot tolerate normal food during an acute flare of gut inflammation, elemental diets offer an alternative approach. These are liquid formulas in which proteins are broken down into individual amino acids, fats are simplified, and carbohydrates are in their most basic forms. Because they require almost no active digestion, they can be absorbed high in the small intestine without provoking immune reactions to intact food proteins. Elemental diets are free of common allergens and have demonstrated anti-inflammatory and mucosal healing properties.23PubMed Central. Elemental Diet as a Therapeutic Modality: A Comprehensive Review

The strongest evidence for elemental diets promoting mucosal healing comes from Crohn’s disease, where exclusive elemental nutrition is recommended as first-line induction therapy in children. In one pediatric study, after six to eight weeks of exclusive elemental nutrition, about 90% of patients showed improvement in intestinal ulcers, with roughly half achieving complete disappearance of ulcers.24Journal of Crohn’s and Colitis. P595 Assessment of mucosal healing after exclusive elemental diet using small bowel capsule endoscopy in paediatric Crohn’s disease While Crohn’s disease is not the same as celiac disease, the principle is relevant: giving the gut a break from complex antigens and inflammatory triggers allows the epithelium to regenerate. For patients with severe malabsorption from villous atrophy of any cause, elemental diets can also serve as a bridge, keeping nutrition adequate while the underlying condition is identified and treated.

The Tight Junction Connection

Villous atrophy does not just reduce surface area for absorption. It also disrupts the tight junctions between epithelial cells, the molecular seals that control what passes between cells from the gut lumen into the bloodstream. In active celiac disease, tight junction proteins like ZO-1 are downregulated, and intestinal permeability increases.25Digestive and Liver Disease. Transcriptional downregulation of tight junction protein ZO-1 in active coeliac disease is reversed after a gluten-free diet This “leaky gut” allows molecules that would normally stay in the intestinal lumen to cross into the tissue, potentially fueling further immune activation. The good news embedded in that same research: ZO-1 expression recovered after patients adopted a gluten-free diet, suggesting that the barrier defect is a consequence of the ongoing immune process rather than a permanent structural change. Once the inflammation resolves, the seals between cells can reform.

This has practical implications beyond celiac disease. Any condition causing villous atrophy likely also compromises barrier function to some degree, which means the consequences extend beyond simple malabsorption. Increased permeability may explain why people with active villous atrophy sometimes react to foods they previously tolerated, or why systemic symptoms like joint pain and fatigue accompany what seems like a purely intestinal problem. As the villi rebuild and tight junctions reseal, these extra-intestinal symptoms often improve as well, though the timeline varies.

Aging and Stem Cell Repair

The difference in recovery speed between children and adults hints at something important about the intestinal stem cells driving that recovery. The same research that showed Lgr5-positive stem cells can restore a damaged crypt within 24 hours also demonstrated that this coordinated repair response is impaired by aging.2Scientific Reports. Intestinal crypts recover rapidly from focal damage with coordinated motion of stem cells that is impaired by aging In older tissue, the stem cells still respond to damage, but they move more slowly toward the injury site and take longer to re-establish a normal cellular pattern. This may partially explain why adult celiac patients need years to achieve the mucosal recovery that children often reach in months.

It also raises questions about other conditions that damage villi in older populations. Environmental enteropathy, medication-induced enteropathy from ARBs (which are prescribed primarily to older adults), and autoimmune conditions all disproportionately affect people whose stem cell repair machinery may already be running at reduced capacity. For these patients, identifying and removing the trigger as early as possible gives the aging regenerative system the best shot at a full recovery, because every additional month of ongoing damage matters more when repair is slower.